Insider Trading & Ownership - NRX PHARMACEUTICALS INC WT EXP (NRXPW)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for NRX PHARMACEUTICALS INC WT EXP
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-08-30
Purchase
2023-09-11
09:19 am
NRX Pharmaceuticals Inc.NRXPGorovitz Aaron
Director
35,000$0.3199$11,197105,000
(Indirect)
View
2023-08-30
Purchase
2023-09-11
09:15 am
NRX Pharmaceuticals Inc.NRXPHurvitz Chaim
Director
70,000$0.2875$20,1252,214,793
(Indirect
Direct)
View
2023-08-23
Purchase
2023-08-24
12:14 pm
NRX Pharmaceuticals Inc.NRXPJavitt Jonathan C
Chief Scientist
10% Owner
100,000$0.33$33,00014,768,329
(Indirect
Direct)
View
2023-08-22
Purchase
2023-08-23
09:24 am
NRX Pharmaceuticals Inc.NRXPJavitt Jonathan C
Chief Scientist
10% Owner
200,000$0.322$64,40014,668,329
(Indirect
Direct)
View
2022-12-16
Purchase
2022-12-19
07:14 am
NRX Pharmaceuticals Inc.NRXPWillard Stephen H
CHIEF EXECUTIVE OFFICER
50,000$1.17$58,50050,000
(Direct)
View
2022-12-16
Purchase
2022-12-19
07:09 am
NRX Pharmaceuticals Inc.NRXPVAN VOORHEES SETH
CHIEF FINANCIAL OFFICER
30,000$1.1$33,00046,337
(Direct)
View
2022-11-25
Purchase(A)
2022-12-19
07:08 am
NRX Pharmaceuticals Inc.NRXPVAN VOORHEES SETH
CHIEF FINANCIAL OFFICER
16,337$1.115$18,21516,337
(Direct)
View
2022-12-07
Sale
2022-12-09
4:33 pm
NRX Pharmaceuticals Inc.NRXPJavitt Jonathan C
Director
10% Owner
400,000$1$400,00014,468,329
(Indirect
Direct)
View
2022-11-29
Sale
2022-12-01
7:29 pm
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
22,171$1.5043$33,3529,634,793
(Indirect)
View
2022-11-28
Purchase
2022-11-29
07:00 am
NRX Pharmaceuticals Inc.NRXPFlynn Patrick John
Director
11,750$1.2479$14,66341,959
(Indirect
Direct)
View
2022-11-25
Purchase
2022-11-28
07:42 am
NRX Pharmaceuticals Inc.NRXPVAN VOORHEES SETH
CHIEF FINANCIAL OFFICER
16,337$1.115$18,21516,377
(Indirect)
View
2022-11-16
Purchase(A)
2022-11-23
4:09 pm
NRX Pharmaceuticals Inc.NRXPHurvitz Chaim
Director
500,000$1.0298$514,905500,000
(Direct)
View
2022-11-16
Purchase
2022-11-21
5:58 pm
NRX Pharmaceuticals Inc.NRXPHurvitz Chaim
Director
500,000$1.0298$514,9052,525,876
(Indirect
Direct)
View
2022-11-16
Sale
2022-11-18
7:05 pm
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
166,737$1.0264$171,1389,656,964
(Indirect)
View
2022-11-11
Sale
2022-11-15
7:40 pm
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
49,200$1.0063$49,5109,823,701
(Indirect)
View
2022-07-29
Sale
2022-08-02
5:43 pm
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
784,063$1.0094$791,4339,872,901
(Indirect)
View
2022-06-03
Sale
2022-06-07
8:11 pm
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
445,712$0.68185$303,91012,656,964
(Indirect)
View
2022-06-01
Purchase(A)
2022-06-02
09:46 am
NRX Pharmaceuticals Inc.NRXPJavitt Jonathan C
Chief Scientist
10% Owner
100,000$0.58$58,00014,868,329
(Indirect
Direct)
View
2022-06-01
Purchase
2022-06-02
08:55 am
NRX Pharmaceuticals Inc.NRXPJavitt Jonathan C
Chief Scientist
10% Owner
100,000$58$5,800,00014,868,329
(Indirect
Direct)
View
2021-08-23
Sale
2021-11-02
4:05 pm
NRX Pharmaceuticals Inc.NRXPDaigneault Alessandra
General Counsel & Secretary
33,715$13.11$442,004308,591
(Direct)
View
2021-09-15
Sale
2021-11-02
4:04 pm
NRX Pharmaceuticals Inc.NRXPBesthof Robert
Chief Comm. & Patient Officer
40,000$11.76$470,400307,200
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing

Ownership
2024-06-26
7:37 pm
N/A
2027-06-14
NRX Pharmaceuticals Inc.NRXPMcBride Dennis
Director
0$06,320
(Direct)
View
2022-12-14
Ownership
2023-02-14
5:14 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPJavitt Jonathan C
Director
10% Owner
300,000$014,468,329
(Indirect)
View
2022-10-21
Option Award
2022-11-22
5:46 pm
N/A
2032-10-21
NRX Pharmaceuticals Inc.NRXPGorovitz Aaron
Director
162,660$0162,660
(Direct)
View
2022-10-21
Option Award
2022-11-22
5:45 pm
N/A
2032-10-21
NRX Pharmaceuticals Inc.NRXPGlied Sharon
Director
162,660$0228,097
(Direct)
View
2022-10-21
Option Award
2022-11-22
5:44 pm
N/A
2032-10-21
NRX Pharmaceuticals Inc.NRXPFlynn Patrick John
Director
162,660$0162,660
(Direct)
View
2022-10-21
Option Award
2022-11-21
5:58 pm
N/A
2032-10-21
NRX Pharmaceuticals Inc.NRXPHurvitz Chaim
Director
162,660$02,525,876
(Direct)
View

Ownership
2022-07-22
4:27 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPWillard Stephen H
Chief Executive Officer
0$01,000,000
(Direct)
View
2022-07-01
Gift
2022-07-05
5:06 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
2,000,000$010,656,964
(Indirect)
View

Ownership
2022-06-29
6:14 pm
2023-06-13
2032-06-12
NRX Pharmaceuticals Inc.NRXPVAN VOORHEES SETH
Chief Financial Officer
0$0325,000
(Direct)
View

Ownership
2022-03-24
6:25 pm
2023-03-15
2032-03-14
NRX Pharmaceuticals Inc.NRXPStrassberg Ira S
Chief Financial Officer
0$0425,000
(Direct)
View
2022-03-08
Option Award
2022-03-10
4:04 pm
N/A
2032-03-08
NRX Pharmaceuticals Inc.NRXPBesthof Robert
Interim CEO
100,000$2.61347,200
(Direct)
View
2021-08-26
Option Award
2021-11-02
4:07 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPMcMaster Herbert Raymond
Director
10,424$045,086
(Direct)
View
2021-08-26
Exercise
2021-11-02
4:07 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPMcMaster Herbert Raymond
Director
18,300$2.2245,086
(Direct)
View
2021-08-26
Conversion
2021-11-02
4:07 pm
N/A
2028-01-04
NRX Pharmaceuticals Inc.NRXPMcMaster Herbert Raymond
Director
28,724$2.2245,086
(Direct)
View
2021-07-16
Gift
2021-11-02
4:06 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
434,594$013,102,676
(Indirect)
View
2021-08-19
Exercise
2021-11-02
4:05 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPDaigneault Alessandra
General Counsel & Secretary
58,979$3.07308,591
(Direct)
View
2021-08-19
Conversion
2021-11-02
4:05 pm
N/A
2030-09-01
NRX Pharmaceuticals Inc.NRXPDaigneault Alessandra
General Counsel & Secretary
92,582$3.07308,591
(Direct)
View
2021-08-19
Option Award
2021-11-02
4:05 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPDaigneault Alessandra
General Counsel & Secretary
33,603$0308,591
(Direct)
View
2021-08-16
Option Award
2021-11-02
4:04 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPBesthof Robert
Chief Comm. & Patient Officer
36,290$0307,200
(Direct)
View
2021-08-16
Exercise
2021-11-02
4:04 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPBesthof Robert
Chief Comm. & Patient Officer
63,710$0.2307,200
(Direct)
View
2021-08-16
Conversion
2021-11-02
4:04 pm
N/A
2026-03-01
NRX Pharmaceuticals Inc.NRXPBesthof Robert
Chief Comm. & Patient Officer
100,000$0.2307,200
(Direct)
View

Ownership
2021-11-02
4:03 pm
N/A
2028-01-04
NRX Pharmaceuticals Inc.NRXPMcMaster Herbert Raymond
Director
0$048,931
(Direct)
View
2021-05-24
Option Award
2021-06-10
6:48 pm
N/A
2028-04-01
NRX Pharmaceuticals Inc.NRXPTroy Daniel
Director
108,530$0108,530
(Direct)
View
2021-05-24
Option Award
2021-06-10
6:48 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPJavitt Jonathan C
Chief Executive Officer
10% Owner
14,817,329$01,468,332
(Direct)
View
2021-05-24
Option Award
2021-06-10
6:48 pm
N/A
N/A
NRX Pharmaceuticals Inc.NRXPJavitt Daniel C.
10% Owner
13,971,864$013,971,864
(Indirect)
View
2021-05-24
Option Award
2021-06-10
6:47 pm
N/A
2021-09-01
NRX Pharmaceuticals Inc.NRXPHurvitz Chaim
Director
1,863,216$0426,866
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next